Toxicology of Industrial Compounds

N.FEDTKE 177
accumulation: a comprehensive model for chemical carcinogenesis, Toxicol.
Lett., 43, 189–200.
CORLEY, R.A., BORMETT, G.A., MARKLEY, B.J. and STACK, C.R., 1993, A
physiologically-based pharmacokinetic model for 2-butoxyethanol and its
metabolite, 2-butoxyacetic acid, The Toxicologist, 13, 355, 1387A.
CORLEY, R.A., BORMETT, G.A. and GHANAYEM, B.I., 1994, Kinetics of 2butoxyethanol
and its major metabolite 2-butoxyacetic acid in rats and humans,
Toxicol. Appl. Pharmacol., submitted.
CSANÁDY, G.A., MENDRALA, A.L., NOLAN, R.J. and FILSER, J.G., 1994, A
physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse,
rat and man, Arch. Toxicol. (in press).
D’SOUZA, R.W., FRANCIS, W.R. and ANDERSEN, M.E., 1988, Physiological
model for tissue glutathione depletion and increased resynthesis after ethylene
dichloride exposure, J. Pharmacol. Exp. Therap., 245, 563–8.
ECETOC, 1985, Technical Report No. 17. The Toxicology of Glycol Ethers and
its Relevance to Man: an Updating of ECETOC Technical Report No. 14,
Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals.
ECETOC, 1994, Special Report No. 7. Butoxyethanol Criteria Document
(including a supplement for 2-butoxyethyl acetate), Brussels: European Centre
for Eco-toxicology and Toxicology of Chemicals.
EEC, 1992, Council Directive 92/32/EEC of 30 April 1992 amending for the 7th
time Council Directive 67/548/EEC on the approximation of laws, regulations
and administrative provisions relating to the classification, packaging and
labelling of substances, Offic. J. Europ. Communities, L 154/1.
EEC, 1993a, Council Regulation EEC 793/93 of 23 March 1993 on the evaluation
and control of the risks of existing substances, Offic. J. Europ. Communities, L
84.
EEC, 1993b, Commission Directive 93/67/EEC of 20 July 1993 laying down the
principles for assessment of risks to man and the environment of substances
notified in accordance with Council Directive 67/548/EEC, Offic. J. Europ.
Communities, L 227/9.
FILSER, J.G., 1992, The closed chamber technique—uptake, endogenous
production, excretion, steady state kinetics and rates of metabolism of gases
and vapours, Arch. Toxicol, 66, 1–10.
FREDERICK, C.B., 1993, Limiting the uncertainty in risk assessment by the
development of physiologically based pharmacokinetic and pharmacodynamic
models, Toxicol. Lett., 68, 159–75.
FREDERICK, C.B., POTTER, D.W., CHANG-MATEU, M.I. and ANDERSEN,
M. E., 1992, A physiologically based pharmacokinetic and pharmacodynamic
model to describe the oral dosing of rats with ethyl acrylate and its implications
for risk assessment, Toxicol. Appl. Pharmacol., 114, 246–60.
GARGAS, M.L., ANDERSEN, M.E. and CLEWELL, H.J., III, 1986, A physiologically
based simulation approach for determining metabolic constants from gas
uptake data, Toxicol. Appl. Pharmacol., 86, 341–52.
GARGAS, M.L., BURGESS, R.J., VOISARD, D.E., CASON, G.H. and
ANDERSEN, M.E., 1989, Partition coefficients of low-weight volatile
chemicals in various liquids and tissues, Toxicol. Appl. Pharmacol., 98, 87–99.